‘Healthy Vaccinee Bias’ May Have Led to Inflated Efficacy Claims of Pfizer’s COVID-19 Booster, Researchers Find

“The authors found a 94.8 percent lower mortality unrelated to COVID-19 among participants in the boosted group and a ‘markedly lower incidence of adverse health outcomes’ in the same group. Additionally, COVID-19 mortality, whether boosted or not, was essentially the same in the 2021 study, generating a ‘strong concern’ vaccine efficacy was overestimated.

In other words, an individual’s underlying health plays a significant role in COVID-19-related mortality. If the boosted group had fewer health conditions that weren’t accounted for in the data, it wouldn’t be accurate to attribute lower mortality to a third dose of Pfizer’s vaccine.”

Full Article: https://bit.ly/3Y7eYXD

@ChiefNerd